• Researchers Identify New Mutation in Gene Linked to CMT Type 4H
  • Safety Board OKs Continuation of Phase 3 Trial of PXT3003 as a Charcot-Marie-Tooth Treatment
  • Pharnext to Hold Charcot-Marie-Tooth Symposium at Marseille Conference
  • Flex Pharma’s New CEO William McVicar to Continue Developing CMT Therapy Candidate FLX-787
  • CMT-Causing Gene Mutation Found in Study of Chinese Family
  • Researchers in Spain Identify 2 Most Common GDAP1 Gene Mutations that Lead to CMT
  • Few Surgeons Use the Same Steps to Correct a Foot Deformity in a CMT Patient, Study Indicates
  • Researchers Study Myelin Protein Mutations and Their Links to Charcot-Marie-Tooth Disease
  • Acceleron Pharma Investigates ACE-083 as Treatment for CMT Patients
  • French Scientists Report Two Novel Mutations Leading to Inherited Form of CMT
  • Molecular Abnormalities Suggest Charcot–Marie–Tooth Starts During Embryonic Development
  • Japanese Study Describes 15 New Variants of MFN2 Gene in Group of Charcot-Marie-Tooth Patients